Inozyme Pharma surges 17% following disclosure of several insider buys

by equitieswatch

April 21, 2022

in Finance

Equitieswatch.com is your Stock Market, Finance, Forex, Cryptocurrency, Business, NFT News Website. We provide you with the latest breaking news and videos straight from the Business industry.

Home
About us
Contact
Privacy Policy

No Result

View All Result

Home
Stock Market
Finance
Cryptocurrency
Commodities

Inozyme Pharma surges 17% following disclosure of several insider buys

The U.S. is hurtling toward a recession. Here’s the best-case scenario for how it could play out—and the worst

Bitcoin Breaches $20,000 for the First Time Since 2020

Search

Recent News

U.S. oil groups urge Biden to take fuel export ban off table -letter By Reuters

Oil climbs ahead of OPEC+ talks on supply cut By Reuters

Exxon signals strong Q3 earnings on natural gas By Reuters

Inozyme Pharma surges 17% following disclosure of several insider buys

YOU MAY ALSO LIKE

The U.S. is hurtling toward a recession. Here’s the best-case scenario for how it could play out—and the worst

Bitcoin Breaches $20,000 for the First Time Since 2020

Search

Recent News

U.S. oil groups urge Biden to take fuel export ban off table -letter By Reuters

Oil climbs ahead of OPEC+ talks on supply cut By Reuters

Exxon signals strong Q3 earnings on natural gas By Reuters